Related Experiment Video
Updated: May 25, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Analysis of p16(CDKN2A) methylation and HPV-16 infection in oral mucosal dysplasia
Thiago Fonseca-Silva1, Lucyana Conceição Farias, Claudio Marcelo Cardoso
1Department of Dentistry, Universidade Estadual de Montes Claros, Montes Claros, Brazil.
Objective:
The purpose of this study was to investigate the relationship between p16(CDKN2A) methylation and epithelial dysplasia (ED). We also evaluated the expressions of proteins related to methylation (DNMT3B and DNMT1). Finally, we tested whether HPV-16/18 or the dmt3b (C46359T) polymorphism is associated with p16(CDKN2A) methylation status.
Methods:
To test the hypothesis, a case-control study with 72 (control, n = 24; ED, n = 48) tissue samples from subjects was performed. Methylation-specific PCR, RFLP, and immunohistochemical analyses were performed to evaluate p16(CDKN2A) methylation status, dmt3b (C46359T) genotyping, and protein levels, respectively.
Results:
The methylation of p16(CDKN2A) and HPV-16 was associated with ED gradation (p = 0.001 and 0.002, respectively). In addition, most HPV-16-positive samples (77.8%) exhibited p16(CDKN2A) methylation; however, changes in DNMT3B and DNMT1 protein levels were not observed in HPV-positive samples. Neither HPV-18 nor the dmt3b polymorphism was associated with p16(CDKN2A) methylation.
Conclusions:
There is an association between the presence of HPV-16 in ED and the occurrence of p16(CDKN2A) methylation. Both variables are also associated with ED development, but further studies are necessary to clarify if they operate independently and if they have any impact on OD malignization.
Insights
p16(CDKN2A) methylation and HPV-16 presence are linked to epithelial dysplasia (ED) development. These factors may play a role in oral cancer progression, warranting further investigation.
Area of Science:
- Oncology
- Molecular Biology
- Virology
Background:
- Epithelial dysplasia (ED) is a precancerous condition.
- p16(CDKN2A) gene methylation is implicated in various cancers.
- Human Papillomavirus (HPV) infection is a known risk factor for dysplasia and cancer.
Purpose of the Study:
- To investigate the association between p16(CDKN2A) methylation and epithelial dysplasia (ED).
- To evaluate the expression of methylation-related proteins (DNMT3B and DNMT1).
- To determine if HPV-16/18 or the dmt3b polymorphism correlates with p16(CDKN2A) methylation status.
Main Methods:
- A case-control study involving 72 tissue samples (24 control, 48 ED).
- Methylation-specific PCR to assess p16(CDKN2A) methylation.
- RFLP for dmt3b (C46359T) genotyping and immunohistochemistry for protein levels.
Main Results:
- p16(CDKN2A) methylation and HPV-16 presence were significantly associated with ED gradation (p=0.001 and p=0.002).
- 77.8% of HPV-16-positive samples showed p16(CDKN2A) methylation.
- No significant changes in DNMT3B or DNMT1 protein levels were observed in HPV-positive samples; HPV-18 and dmt3b polymorphism were not linked to p16(CDKN2A) methylation.
Conclusions:
- An association exists between HPV-16, p16(CDKN2A) methylation, and ED.
- Both HPV-16 and p16(CDKN2A) methylation are linked to ED development.
- Further research is needed to clarify their independent roles and impact on oral cancer progression.
Related Concept Videos
Cellular Adaptation IV: Dysplasia and Metaplasia
Abnormal Proliferation

